Anson Funds Management’s Universe Pharmaceuticals Inc UPC Stock Holding History

Anson Funds Management’s Portfolio UPC Stock Details UPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-5,760	Closed	-$141K	–	181
2024 Q4	$141K	Buy	+5,760	New	+$668K	0.01%	137

Other funds holding UPC

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Anson Funds Management's UPC Position: Q1 2025 in Review

Anson Funds Management sold out of Universe Pharmaceuticals Inc (UPC) in Q1 2025, closing a stake of 5,760 shares — an estimated $141K sold.

Anson Funds Management first reported a position in UPC in Q4 2024 and held it in 1 quarter. The position peaked at $141K in Q4 2024. 1 fund tracked by Wall St. Rank holds UPC as of Q1 2025.

Anson Funds Management reported no remaining Universe Pharmaceuticals Inc position as of Q1 2025 after selling out during the quarter.
Anson Funds Management sold 5,760 Universe Pharmaceuticals Inc shares in Q1 2025, an estimated $141K.
Anson Funds Management first reported a position in Universe Pharmaceuticals Inc in Q4 2024 and held it in 1 quarter.
Anson Funds Management's Universe Pharmaceuticals Inc position peaked at $141K in Q4 2024.
1 fund tracked by Wall St. Rank held Universe Pharmaceuticals Inc as of Q1 2025.

Based on Anson Funds Management's 13F filing for Q1 2025, filed 14 May 2025.